Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11221799 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL381403 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2238752 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2238442 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL9304975 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2239219 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL23888724 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL2237184 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL7754974 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 | |
| SCHEMBL3540013 | 1.00 | DNM1 (0.46) | DNM1SPHK1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220363976-A1 | ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES | CHAMPIONX LLC | 2022-11-17 | — | — | US | claimed |
| US-9260559-B2 | Processes for the preparation of rheology modifiers | ELEMENTIS SPECIALTIES, INC. (US) | 2016-02-16 | — | — | US | claimed |
| EP-2759555-B1 | Processes for the preparation of rheoloy modifiers | ELEMENTIS SPECIALTIES INC (US) | 2016-02-03 | — | — | EP | claimed |
| EP-2759555-A1 | Processes for the preparation of rheoloy modifiers | Elementis Specialties, Inc. (US) | 2014-07-30 | — | — | EP | claimed |
| US-20140135468-A1 | PROCESSES FOR THE PREPARATION OF RHEOLOGY MODIFIERS | ELEMENTIS SPECIALTIES, INC. | 2014-05-15 | — | — | US | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |
| EP-4127119-B1 | WATER-GLYCOL HYDRAULIC FLUID | SHELL INT RESEARCH (NL) | 2025-08-27 | — | — | EP | disclosed |
| US-12187977-B2 | Water-glycol hydraulic fluid | SHELL USA, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| EP-4127117-B1 | WATER/GLYCOL-BASED HYDRAULIC FLUID | SHELL INT RESEARCH (NL) | 2024-10-30 | — | — | EP | disclosed |
| EP-4244317-B1 | WATER-GLYCOL HYDRAULIC FLUID | SHELL INT RESEARCH (NL) | 2024-07-31 | — | — | EP | disclosed |
| US-11946015-B2 | Water glycol-based hydraulic fluid | SHELL USA, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| US-11946014-B2 | Water/glycol-based hydraulic fluid | SHELL USA, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| EP-0200001-A1 | Process for coating a metal surface with a lubricating oil | NIHON PARKERIZING CO., LTD. (JP) | 1986-11-05 | — | — | EP | disclosed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | disclosed |
| US-4438235-A | POLYETHERS, POLYESTERS, POLYURETHANES | BASF WYANDOTTE CORPORATION (US) | 1984-03-20 | — | — | US | disclosed |
| US-4294940-A | A CATIONIC POLYMER OF A CONJUGATED DIENE MODIFIED BY AN UNSATURATED ACID OR ANHYDRIDE, ALCOHOL OR AMINE, EPOXY COMPOUND, AND BLOCKED POLYISOCYANATE; AUTO PAINTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-10-13 | — | — | US | disclosed |
| US-4130510-A | Curing of epoxy resin systems using halfester compounds containing aliphatic tertiary amino groups | HITACHI CHEMICAL CO., LTD. (JP) | 1978-12-19 | — | — | US | disclosed |
| US-4059581-A | Heterocyclic nitrogen containing siloxanes | UNION CARBIDE CORPORATION (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363976-A1 | ALKYL LACTONE-DERIVED HYDROXYAMIDES AND ALKYL LACTONE-DERIVED HYDROXYESTERS FOR THE CONTROL OF NATURAL GAS HYDRATES | HDHD5, HACL2, ADH5 | DNM1 2930/4885SPHK1 2030/4885CA12 313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.